1. Home
  2. TBPH vs EGY Comparison

TBPH vs EGY Comparison

Compare TBPH & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • EGY
  • Stock Information
  • Founded
  • TBPH 2013
  • EGY 1985
  • Country
  • TBPH United States
  • EGY United States
  • Employees
  • TBPH N/A
  • EGY N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • EGY Oil & Gas Production
  • Sector
  • TBPH Health Care
  • EGY Energy
  • Exchange
  • TBPH Nasdaq
  • EGY Nasdaq
  • Market Cap
  • TBPH 485.8M
  • EGY 497.4M
  • IPO Year
  • TBPH N/A
  • EGY N/A
  • Fundamental
  • Price
  • TBPH $9.59
  • EGY $4.30
  • Analyst Decision
  • TBPH Buy
  • EGY Strong Buy
  • Analyst Count
  • TBPH 4
  • EGY 1
  • Target Price
  • TBPH $13.75
  • EGY $8.00
  • AVG Volume (30 Days)
  • TBPH 217.1K
  • EGY 1.1M
  • Earning Date
  • TBPH 11-12-2024
  • EGY 11-11-2024
  • Dividend Yield
  • TBPH N/A
  • EGY 5.80%
  • EPS Growth
  • TBPH N/A
  • EGY 170.05
  • EPS
  • TBPH N/A
  • EGY 0.86
  • Revenue
  • TBPH $63,192,000.00
  • EGY $506,421,000.00
  • Revenue This Year
  • TBPH $11.41
  • EGY $0.48
  • Revenue Next Year
  • TBPH $37.36
  • EGY N/A
  • P/E Ratio
  • TBPH N/A
  • EGY $4.99
  • Revenue Growth
  • TBPH 15.93
  • EGY 25.82
  • 52 Week Low
  • TBPH $7.44
  • EGY $4.03
  • 52 Week High
  • TBPH $11.71
  • EGY $7.51
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 50.13
  • EGY 23.56
  • Support Level
  • TBPH $9.62
  • EGY $4.74
  • Resistance Level
  • TBPH $10.08
  • EGY $4.76
  • Average True Range (ATR)
  • TBPH 0.31
  • EGY 0.21
  • MACD
  • TBPH -0.06
  • EGY -0.05
  • Stochastic Oscillator
  • TBPH 25.00
  • EGY 7.77

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea and Corporate and Other. The company generates maximum revenue from the Gabon segment.

Share on Social Networks: